These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19096973)

  • 1. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients.
    Morgan PE; Sturgess AD; Davies MJ
    Free Radic Res; 2009 Feb; 43(2):117-27. PubMed ID: 19096973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis.
    Morgan PE; Sturgess AD; Hennessy A; Davies MJ
    Free Radic Res; 2007 Dec; 41(12):1301-12. PubMed ID: 17957542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the relationship between protein oxidation and disease activity in systemic lupus erythematosus].
    Zhang Q; Ye DQ; Chen GP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):181-4. PubMed ID: 18686862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus.
    Khan F; Siddiqui AA; Ali R
    Scand J Immunol; 2006 Nov; 64(5):507-14. PubMed ID: 17032243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
    Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
    Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic activity in sera of patients with systemic lupus erythematosus.
    Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
    Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
    Rovin BH; Song H; Birmingham DJ; Hebert LA; Yu CY; Nagaraja HN
    J Am Soc Nephrol; 2005 Feb; 16(2):467-73. PubMed ID: 15601744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
    Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
    Yang DH; Chang DM; Lai JH; Lin FH; Chen CH
    Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative protein damage and antioxidant status in systemic lupus erythematosus.
    Zhang Q; Ye DQ; Chen GP; Zheng Y
    Clin Exp Dermatol; 2010 Apr; 35(3):287-94. PubMed ID: 19874339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.